Triptorelin: legal
This page summarises Triptorelin's status in the places checked; it is not legal advice, and it does not cover every country or state.
United States
Triptorelin does not appear by name anywhere in the federal “Schedules of Controlled Substances”, read in full on 2026-11-19.[1] It is an approved prescription medicine: the FDA's records list “TRELSTAR” and “TRIPTODUR KIT”, both “TRIPTORELIN PAMOATE”, with marketing status “Prescription”.[2] Approval covers those products from their makers, dispensed on prescription; vials sold online as research triptorelin are not those products. Not being federally scheduled is not the same as being legal to sell for consumption, and state law was not checked for this page.
Sport
The World Anti-Doping Agency's list, which states “This List shall come into effect on 1 January 2026.”, lists “Testosterone-stimulating peptides in males including, but not limited to:” gonadorelin's “(GnRH, gonadorelin) and its agonist analogues”, ending its examples with “nafarelin and triptorelin)”.[3] The ban is worded for males. That section is headed “PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION)”, so it applies out of competition as well, and states: “All prohibited substances in this class are non-Specified Substances.”[3] Non-specified means the list treats a positive test as more likely to be deliberate.
References
- 21 CFR part 1308, Schedules of Controlled Substances, full text as of 2026-11-13 (eCFR versioner, read 2026-11-19) — US Drug Enforcement Administration, via eCFR (National Archives)
- Drugs@FDA application records with triptorelin%20pamoate as an active ingredient (openFDA drugsfda endpoint, read 2026-11-19) — US Food and Drug Administration, via openFDA
- World Anti-Doping Code International Standard: Prohibited List 2026, Wayback capture of 19 November 2026 — World Anti-Doping Agency
Comments
Sign in to join the conversation.
No comments yet.